TTP and CellFiber working together to enable scalable cell production for use in cell and gene therapies.
TTP’s transition to 100% employee ownership is believed to represent one of the largest EOT deals in the UK by deal value.
Experts, business leaders and researchers from over 30 companies convened at the HQ of TTP plc on Wednesday 15th September for its first ever Cell and Gene Therapy (CGT) Summit.
TTP plc, a leading independent UK technology and product development company, has announced the opening of a brand new dedicated manufacturing facility at its HQ in Cambridge.
Until we start to feel the impact of the vaccine rollout, we need to develop safe, reliable and rapid mechanisms which could allow schools to stay open and stop important sections of the economy, such as the hospitality sector, from having to close their doors completely again. That’s where our focus has been.
TTP has partnered with Hovione Technology and H&T Presspart to design a new respiratory device; the PowdAir® Plus Dry Powder Inhaler (DPI)
Sam Hyde shares his views with Red Box for The Times.
TTP consultant, Douglas Bradsahw, was interviewed on Sky News, Ian King Live and discussed CoTest™, TTP's new COVID-19 screening technology to to be used by anyone, anywhere, to screen up to 40 people at once for Covid-19 with results available in 30 minutes.
The Technology Partnership Plc (TTP), a leading independent technology and product development company, is seeking go-to-market partnerships for CoTest, a new pooled screening technology for Covid-19.
Cambridge Half Marathon has announced that Cambridgeshire based independent technology company, TTP, has become the Title Partner of the race ahead of its tenth anniversary in 2021.
